COIOSDeep risk insights through multi-disciplinary research across the globe
Boats moored along a canal lined with trees and historic buildings in Amsterdam
Item refines Peer-reviewed Added

APOE ε4 carriers show steeper age-related changes in plasma Alzheimer's disease biomarkers

In 5,913 cognitively normal Dutch adults, three plasma Alzheimer's biomarkers diverged by APOE ε4 status between ages 53 and 63.

Plasma p-tau217, amyloid-β-42/40, NfL and GFAP were measured in 5,913 cognitively normal Netherlands Twin Register adults aged 30 to 80. The study tested how APOE ε4, a polygenic risk score excluding APOE, age and sex related to these biomarkers. Carriers and non-carriers diverged at 53.2 years for amyloid-β-42/40, 58.8 for p-tau217 and 62.8 for GFAP, but not for NfL. The polygenic risk score did not alter how any biomarker changed with age. In 202 older twins with amyloid PET scans, p-tau217 rose faster where amyloid was present. Carrying ε4 was linked to an earlier rise. The main cohort was cross-sectional and family-based, and cognition was not formally tested.

Why it is interesting: Plasma p-tau217, amyloid-β-42/40 and GFAP differed by APOE ε4 status 15 to 20 years before estimated mean clinical onset. These differences appeared in adults reporting no memory complaints.

Source
Nature Communications, 16 November 2026
DOI
10.1038/s41467-026-78723-2
Full text
Open copy (open-access copy, PubMed Central)
Type
Peer-reviewed article
Design
Population-based cross-sectional cohort analysis, Netherlands Twin Register, n=5913 aged 30-80, with longitudinal replication in EMIF-AD
Verdict
Refines prior evidence
Driver
Dementia
Driver
What linked data reveals

Other drivers in Health today